Johnson & Johnson asks US regulators to OK its one-shot COVID-19 vaccine
New Brunswick-based Johnson & Johnson has asked U.S. regulators to clear the world’s first single-dose COVID-19 vaccine, an easier-to-use option that could boost scarce supplies.
Share:
